All stock lists
ExxonMobil Holdings Corporation (New York Stock Exchange:XOM)
US · Delayed Price · Currency is USD
Also listed: 7DZ.DE, XOM.MX, XOM.SWEnergy · Oil & Gas Integrated
$169.78+$3.08 (+1.84%)
Market cap
$693B
Insider Score
Health Score
Analyst consensus
Listed since
Jan 13, 1978
Website
Insider Score
––Not scored
XOM Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From XOM’s reported statements · Q3 2026 (trailing 12 months)
Profitability15 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $388.23B
- Net income
- $40.62B
- Net margin
- 10.5%
Leverage19 / 20
Little or no net debt.
- Total debt
- $34.25B
- Cash
- $12.15B
- Net debt / EBITDA
- 0.27x
Liquidity9 / 20
Covers near-term obligations, without much room.
- Current assets
- $107.63B
- Current liabilities
- $90.21B
- Current ratio
- 1.19
Cash generation18 / 20
The business funds itself from operations.
- Operating cash flow
- $70.59B
- Free cash flow
- $42.96B
- FCF margin
- 11.1%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 4140.0M
- Share growth (1y)
- -4.4%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
XOM Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $110.50 B | $114.53 B | $83.16 B | $80.04 B | $83.33 B | $79.48 B |
| Revenue Growth (YoY) | 32.61 % | 44.10 % | 2.59 % | -1.26 % | -5.08 % | -11.68 % |
| Cost of Revenue | $83.84 B | $88.89 B | $51.80 B | $64.92 B | $64.65 B | $61.53 B |
| Gross Profit | $26.66 B | $25.63 B | $31.36 B | $15.12 B | $18.68 B | $17.95 B |
| SG&A Expense | $2.68 B | $2.48 B | $2.68 B | $2.62 B | $3.03 B | $2.53 B |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $7.90 B | $7.44 B | $26.07 B | $9.11 B | $9.51 B | $9.04 B |
| Operating Income | $18.76 B | $18.20 B | $5.29 B | $6.00 B | $9.18 B | $8.91 B |
| Pretax Income | $21.24 B | $19.42 B | $6.97 B | $8.03 B | $10.93 B | $10.71 B |
| Tax Provision | $5.21 B | $4.54 B | $2.50 B | $1.42 B | $3.16 B | $3.35 B |
| Net Income | $15.41 B | $14.53 B | $4.18 B | $6.50 B | $7.55 B | $7.08 B |
| EPS (Basic) | $3.72 | $3.48 | $1.00 | $1.53 | $1.76 | $1.64 |
| EPS (Diluted) | $3.72 | $3.48 | $1.00 | $1.53 | $1.76 | $1.64 |
| Shares Outstanding | 4.14 B | 4.17 B | 4.18 B | 4.24 B | 4.33 B | 4.33 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.